SELLAS Life Sciences Group Vs. Galectin Therapeutics Industry Stock Comparison

Sell

6

SLS
SELLAS Life Sciences Group

Last Price:

$0.90

Seasonality Move:

2.47%

Sell

14

GALT
Galectin Therapeutics

Last Price:

$1.03

Seasonality Move:

33.46%

Sell

6

SELLAS Life Sciences Group (SLS) is a Sell

Is SELLAS Life Sciences Group a Buy, Sell or Hold?

The current SELLAS Life Sciences Group [SLS] share price is $0.90. The Score for SLS is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
SLS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

14

Galectin Therapeutics (GALT) is a Sell

Is Galectin Therapeutics a Buy, Sell or Hold?

The current Galectin Therapeutics [GALT] share price is $1.03. The Score for GALT is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
GALT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

SLS Stock Price Chart

What is SELLAS Life Sciences Group's stock price today?

The SELLAS Life Sciences Group share price today is $0.90

The current trend is relatively stagnant and SLS is experiencing slight buying pressure.

GALT Stock Price Chart

What is Galectin Therapeutics's stock price today?

The Galectin Therapeutics share price today is $1.03

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GALT is experiencing slight selling pressure.

SLS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.09	Sell
Relative Strength Index (14 RSI):	35.76	Sell
Chaikin Money Flow:	30714	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.93 - 1.23)	Sell
Bollinger Bands (100):	(1.09 - 1.31)	Sell

GALT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.25	Sell
Relative Strength Index (14 RSI):	20.76	Sell
Chaikin Money Flow:	-1963460	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.91 - 2.81)	Sell
Bollinger Bands (100):	(2.2 - 2.82)	Sell

SLS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.89	Buy
20-day SMA:	1.04	Sell
50-day SMA:	1.15	Sell
200-day SMA:	1.24	Sell
8-day EMA:	0.92	Sell
20-day EMA:	1.01	Sell
50-day EMA:	1.11	Sell
200-day EMA:	1.21	Sell

GALT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.94	Sell
20-day SMA:	2.26	Sell
50-day SMA:	2.51	Sell
200-day SMA:	2.64	Sell
8-day EMA:	1.86	Sell
20-day EMA:	2.15	Sell
50-day EMA:	2.4	Sell
200-day EMA:	2.46	Sell

SELLAS Life Sciences Group Earnings Growth & SLS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and an increase next year of $0.07 per share.

Galectin Therapeutics Earnings Growth & GALT Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

SELLAS Life Sciences Group Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20
	Dec
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Galectin Therapeutics Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20
	Dec
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):